La hipoglucemia en pacientes con diabetes mellitus tipo 2 en Puerto Rico

Page 1

Perfil del asma EN PUERTO RICO

LA HIPOGLUCEMIA en pacientes con diabetes mellitus tipo 2

Tratamientos quirúrgicos y no

en Puerto Rico

QUIRÚRGICOS EN EL MANEJO DE LA ENFERMEDAD DE PARKINSON

NOW APPROVED FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

SCAN TO LEARN MORE

Selected Important Safety Information STELARA® is an immunosuppressant and may increase the risk of infections, reactivation of latent infections, and malignancies. Serious adverse reactions have been reported in STELARA®-treated patients, including bacterial, fungal, and viral infections, malignancies, hypersensitivity reactions, one case of Reversible Posterior Leukoencephalopathy Syndrome (RPLS), and noninfectious pneumonia. STELARA® should not be given to patients who have had clinically significant hypersensitivity to ustekinumab (or excipients) or patients with any clinically important active infection. Patients should be evaluated for tuberculosis prior to initiating treatment with STELARA®. Live vaccines should not be given to patients receiving STELARA®. If RPLS is suspected or if noninfectious pneumonia is confirmed, discontinue STELARA®. Please see related and other Important Safety Information on reverse.

Suplemento Especial

Ryan White

la historia que cambió la forma de ver el sida

Los nuevos horizontes

terapéuticos del VIH

Correlación entre el VIH

y el virus de la hepatitis C


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
La hipoglucemia en pacientes con diabetes mellitus tipo 2 en Puerto Rico by Revista Medicina y Salud Pública (MSP) - Issuu